RNA interference is a cellular mechanism that uses the gene’s DNA sequence to turn it off, a process that researchers call silencing. RNAi is triggered by double-stranded RNA (dsRNA) in a wide variety of organisms, including animals, plants, and fungi; RNAi is triggered by double-stranded RNA (dsRNA). It is widely used by researchers to silence genes to learn something about their function. Additionally, the ability to turn off the expression of a single gene makes RNAi an appealing therapeutic approach to treat genetic disorders or infectious diseases, such as those that result from the undesirable & inappropriate activity of a gene. Furthermore, RNAi is used in functional genomics and developing therapies to treat many types of cancers, viral infections, neurological disorders, and dominant disorders.
Global RNAi technology market size will grow at a significant CAGR during the forecasting period 2020–2027. The market’s growth can be attributed to its applications such as cancer treatment, treatment of viruses, parasites, bacterial diseases, maladaptive genetic mutations, control drug consumption, provide pain relief, and even modulate sleep. Additionally, in biotechnology & other fields, improving plant resistance to viral diseases resulted in novel crops such as decaffeinated coffee, nicotine-free tobacco, nutrient fortified vegetation, and hypoallergenic crops. Thus increasing applications is expected to drive the growth of the RNAi market during the forecast period. Moreover, It is a specific, potent, and highly successful technique for studying mammalian gene function and animal models and has long been a method of choice for researchers making the loss of function studies.
Furthermore, it becomes an important tool for drug discovery and biomedical research. RNAi screening is even more powerful when combined with high content imaging and data analysis techniques. The resulting multiparametric readouts provide greater insight into the understanding of gene function and their role in disease is expected to contribute to the growth of the health care industry in the forecast period.
RNAi technology has proven to be a powerful tool for researchers to silence genes to learn about their function. RNAi therapy field provides an opportunity to deliver novel drugs that could change patients’ lives, but a critical challenge is developing highly efficient pipelines for the cost-effective selection of RNAi drug candidates. Despite this, there are currently several clinical trials testing the safety and effectiveness of siRNA drugs which can be manufactured cheaply and designed to match any gene. Additionally, therapies based on RNAi are also currently being developed for viral infection, including hepatitis B and C viruses, respiratory syncytial virus, and human immunodeficiency virus. Strategies for the treatment of neurodegenerative diseases and cancers are also responsible for the growth of the global RNAi technology market in the future.
Based on the application, the global RNAi technology market is segregated into drug discovery & development, therapeutics, agriculture, and others. Moreover, therapeutics is further segment into oncology, ocular disorders, respiratory disorders, liver diseases, neurology, cardiology, ophthalmology, and metabolic disorders. The oncology segment held a higher revenue share in 2019 and is projected to dominate the RNAi technology market by 2027. It is primarily attributed to the increasing number of cancer patients in need of treatment and adoptive cell transfer therapy to cure treatment. The agricultural segment will grow with a lucrative growth rate in the forecast period. It is due to improved traits related to disease management, plant development, and crop improvement.
Based on the end-user, the global RNAi technology market is segmented into pharmaceutical & biotechnologies industries, agriculture-based industries, academic & research institutions, contract research organizations, and others. The pharmaceutical & biotechnology companies segment will dominate the global RNAi technology market by 2027. It is due to the demand for personalized medicine, increasing chronic diseases, an adaptation of reagents, and cellular research.
The agricultural segment is expected to grow significantly during the forecast period due to the invention of novel crops and crop improvement.
The global RNAi technology market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa by geography. North America is assigned a significant share by 2027 in the RNAi technology market. The growth in the region can be stated to the growing importance of advanced technology and expansion in the health care sector.
The Asia Pacific is expected to provide significant growth opportunities due to rising disease & their control and the production of animal models for research use.
Companies such as Alnylam Pharmaceuticals, Invitrogen, Benitec Biopharma Ltd, miRagen Therapeutics, Arrowhead, Filmtec Corporation, Ionis Pharmaceuticals, Quark Pharmaceuticals Inc, RXI Pharmaceuticals, Qiagen, Akcea Therapeutics, Alnylam Pharmaceuticals, Gotham Therapeutics, CureVac, BioNTech, Dicerna Pharmaceuticals, Ambion and Gradalis are the key players in the global RNAi technology market.
By Application
By End-User
By Region
Analyst support
After evaluating your requirements and addressing your technical problems, the expert analyst will resolve your query directly.
Customer satisfaction
According to your needs, our expert team will assist you with the capabilities, services, and proper research needs to be required and customize the report accordingly.
Inimitable expertise
Our expert team will create unrivaled reviews to provide you with a deep understanding of the reports.
Assured quality
We have created a systematic way to determine standards and satisfy your expectations.
Instant delivery
Unlike others, we provide you a great deal of instant delivery in the form of PDF/PPT/Word Doc directly to your email address within 24 hours after receiving full payment.
Privacy policy
We understand the inkling of your privacy, we will never misuse your email address.
Custom research service
We are giving you an opportunity through which you can directly ask our expert analyst to customize an exclusive study of the report to serve your research needs.
Quality & accuracy
We provide you with the accurate quality of the customized study of an exclusive report according to your research need.
Data visualization
As the business world’s growing faster every day, we understand the value of data management. We will create the reports by keeping all the visual data sets and metrics in the charts.
Information security
We truly respect your privacy and promise to keep your personal and confidential information safe and secure.